Guardant Health
GH
#1177
Rank
$19.78 B
Marketcap
$149.22
Share price
4.39%
Change (1 day)
193.39%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of March 2026 : $1.70 Billion USD

According to Guardant Health 's latest financial reports the company's total debt is $1.70 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$1.71 B28%
2024-12-31$1.33 B-1.31%
2023-12-31$1.35 B-1.13%
2022-12-31$1.36 B-0.32%
2021-12-31$1.37 B60.77%
2020-12-31$0.85 B2015.28%
2019-12-31$40.39 M
2018-12-31N/A-100%
2017-12-31$0.65 M-96.13%
2016-12-31$17.03 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Neogen
NEOG
$0.79 B-53.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
$0.24 B-85.92%๐Ÿ‡บ๐Ÿ‡ธ USA